MRSA

Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024

Retrieved on: 
Vendredi, mai 3, 2024
Infection, Kidney, FDA, Administration, Staphylococcus, ASPR, HHS, SAB, Safety, Ceftobiprole, Methicillin-resistant Staphylococcus aureus, Food, Ceftriaxone, ESCMID, Daptomycin, Partnership, Fungal infection, Development, CABP, TARGET, ABSSSI, Patient, Staphylococcus aureus, Dialysis, Bronchopneumonia, MRSA, Vaccine

Data presented on a third poster demonstrated that bloodstream clearance was achieved at a median of four days after the start of treatment in both the ceftobiprole and comparator groups.

Key Points: 
  • Data presented on a third poster demonstrated that bloodstream clearance was achieved at a median of four days after the start of treatment in both the ceftobiprole and comparator groups.
  • In the group treated with ceftobiprole, fewer patients had Staphylococcus aureus-positive blood cultures after ten days compared to the comparator treatment group.
  • An oral presentation focused on a re-analysis of the previously conducted ceftobiprole phase 3 study in patients with community-acquired bacterial pneumonia (CABP).
  • Using the FDA-CABP-2020 primary endpoint of early clinical success at day 3 after study start, this re-analysis supported the non-inferiority of ceftobiprole to ceftriaxone ± linezolid.

OsteoRemedies® Obtains Expanded Indications for SPECTRUM® Dual Antibiotic Bone Cement

Retrieved on: 
Mardi, avril 23, 2024
FDA, Patient, Research, MRSA, Infection, Vancomycin

MEMPHIS, Tenn., April 23, 2024 /PRNewswire/ -- OsteoRemedies® LLC, an orthopedic company focused on providing simple solutions to complex disorders, has announced FDA clearance for expanded indications for the SPECTRUM® GV Bone Cement.

Key Points: 
  • MEMPHIS, Tenn., April 23, 2024 /PRNewswire/ -- OsteoRemedies® LLC, an orthopedic company focused on providing simple solutions to complex disorders, has announced FDA clearance for expanded indications for the SPECTRUM® GV Bone Cement.
  • Initially launched in 2018, SPECTRUM® GV Bone Cement is the first commercially available dual antibiotic bone cement on the US market.
  • Containing both vancomycin and gentamicin, SPECTRUM® GV Bone Cement prevents bacterial adhesion of susceptible organisms, intermediate-resistant, and methicillin-resistant staphylococcal infections.
  • From a mechanical performance perspective, testing of SPECTRUM® GV Bone Cement has been compared to commercially available single antibiotic bone cements and found to have substantially equivalent mechanical integrity.

Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications

Retrieved on: 
Jeudi, avril 4, 2024
Disease, MSSA, MRSA, Development, TARGET, Associate, Partnership, CABP, New Drug Application, Patient, HHS, Mortality, NDA, Fungal infection, Staphylococcus aureus, Bronchopneumonia, Infection, Safety, SAB, ASPR, Staphylococcus, Ceftobiprole, Administration, FDA, ABSSSI, Pharmaceutical industry

David Veitch, Chief Executive Officer of Basilea, said: “We are excited with the US approval of ZEVTERA.

Key Points: 
  • David Veitch, Chief Executive Officer of Basilea, said: “We are excited with the US approval of ZEVTERA.
  • The positive decision by the FDA is a key milestone towards bringing ZEVTERA to patients in the US.
  • This approval is a landmark for ceftobiprole and reflects its broad clinical utility.
  • Through this partnership, Basilea has been awarded approximately USD 112 million, or approximately 75 percent of the costs related to the SAB and ABSSSI phase 3 studies, regulatory activities and non-clinical work.

$3.8 Billion MRSA Drugs Markets by Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region - Global Forecast to 2032 - ResearchAndMarkets.com

Retrieved on: 
Vendredi, mars 29, 2024
Health, Pharmaceutical, MRSA, Urbanization, Growth, Prevalence, Fungal infection, Pharmacy, Research, Bacteria, Genetically modified bacteria, Tetracycline, Infection, Skin, Lipopeptide, Market, Administration, CA-MRSA, Pharmaceutical industry

The "MRSA Drugs Market by MRSA Type, Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "MRSA Drugs Market by MRSA Type, Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.
  • Moreover, the augmenting awareness regarding different forms of bacterial infection is leading to a higher uptake of MRSA drugs.
  • The report has provided a detailed breakup and analysis of the MRSA drugs market based on the MRSA type.
  • The report has provided a detailed breakup and analysis of the MRSA drugs market based on the route of administration.

Cyclone Technology Launches Specialized Hard Surface Cleaning Treatments, Sports Surface Cleaning Solutions

Retrieved on: 
Mardi, mars 26, 2024
Salt, MRSA, Friction, Oil, Pressure, Tears, Growth, Cyclone, Sport, Infection, Perspiration, Boeing, Aviation, Wax, Bacteria, Athlete, McDonnell Douglas, EPA, Water, Blood, Sweat & Tears, Blood

PHOENIX, March 26, 2024 /PRNewswire/ -- Cyclone Technology, a global leader of high-pressure, hot water, full-recovery cleaning equipment for hard surfaces, today announced the official debut of an innovative line of eco-friendly cleaning treatments, as well as the introduction of Sports Surface Cleaning solutions. Cyclone's innovative solutions are gaining nationwide acclaim as the go-to solution across industries including aviation, entertainment, construction, industrial, motorsports, municipal and military.

Key Points: 
  • PHOENIX, March 26, 2024 /PRNewswire/ -- Cyclone Technology , a global leader of high-pressure, hot water, full-recovery cleaning equipment for hard surfaces, today announced the official debut of an innovative line of eco-friendly cleaning treatments, as well as the introduction of Sports Surface Cleaning solutions.
  • The solutions are designed for use with Cyclone's hard surface cleaning systems and are biodegradable, non-caustic, non-flammable, and highly effective.
  • Specialized Cyclone Clean cleaning treatments include:
    Degreaser - Quickly breaks down and safely removes exhaust soot, hydraulic fluids, fuel residue, oils, dirt, grease, waxes, polishing compounds, salts, soluble oils and other compounds from hard surfaces.
  • For further information on Cyclone Technology's cleaning treatments, sports surface cleaning solutions, and a comprehensive range of hard surface cleaning solutions available for rental or purchase, please visit www.cycloneclean.com .

Seegene and Springer Nature Announce Awardees for the Open Innovation Program

Retrieved on: 
Vendredi, mars 15, 2024
Microsoft, PCR, MRSA, Azure, Automation, Urinary tract infection, Knowledge, Research, UTI, Real-time, Methicillin-resistant Staphylococcus aureus, STI, Clinical trial, GMT, USD, Medical device

In September 2023, Seegene and Springer Nature opened applications to scientists and experts across the global community to conduct research for the 15 designated projects to develop Seegene's syndromic qPCR diagnostics assay reagents for the Open Innovation Program.

Key Points: 
  • In September 2023, Seegene and Springer Nature opened applications to scientists and experts across the global community to conduct research for the 15 designated projects to develop Seegene's syndromic qPCR diagnostics assay reagents for the Open Innovation Program.
  • During the initial stage of document screening, a total of 281 applications were submitted from 47 different countries, demonstrating worldwide interest in the program.
  • The total number of selected awardees is 17, including those who applied for more than one project.
  • The inaugural Open Innovation Program marks the initial step in this endeavor.

Seegene and Springer Nature Announce Awardees for the Open Innovation Program

Retrieved on: 
Vendredi, mars 15, 2024
Microsoft, PCR, MRSA, Azure, Automation, Urinary tract infection, Knowledge, Research, UTI, Real-time, Methicillin-resistant Staphylococcus aureus, STI, Clinical trial, GMT, USD, Medical device

In September 2023, Seegene and Springer Nature opened applications to scientists and experts across the global community to conduct research for the 15 designated projects to develop Seegene's syndromic qPCR diagnostics assay reagents for the Open Innovation Program.

Key Points: 
  • In September 2023, Seegene and Springer Nature opened applications to scientists and experts across the global community to conduct research for the 15 designated projects to develop Seegene's syndromic qPCR diagnostics assay reagents for the Open Innovation Program.
  • During the initial stage of document screening, a total of 281 applications were submitted from 47 different countries, demonstrating worldwide interest in the program.
  • The total number of selected awardees is 17, including those who applied for more than one project.
  • The inaugural Open Innovation Program marks the initial step in this endeavor.

Cherry Launches Disinfectable Mouse and Keyboard Set for Hygiene-Sensitive Areas at HIMSS

Retrieved on: 
Lundi, mars 11, 2024
Scroll, CE, Hospital, MRSA, Disinfectant, FCC, USB, MDR, IP68, Peter Hancock (professor), Sleep, Methicillin-resistant Staphylococcus aureus, Computer, University, Cherry, Movement, Hygiene, Tablet, Laboratory, Research, Mouse, Typesetting

The new hygiene desktop is ideal for extensive entry in hospitals, doctors' surgeries, laboratories, other healthcare facilities, where disinfecting devices is mandatory.

Key Points: 
  • The new hygiene desktop is ideal for extensive entry in hospitals, doctors' surgeries, laboratories, other healthcare facilities, where disinfecting devices is mandatory.
  • When cleaning standard office keyboards, (even when internally sealed) contaminated cleaning fluids can potentially leak out of the gaps.
  • It is also possible the functionality could be impaired if liquids seep into the keyboard housing.
  • The Hygiene Desktop 2 is an individually configurable set consisting of the AK-C8112 hygiene keyboard and the AK-PMH3 3-Button Scroll and AK-PMH3 Scroll Sensor hygienic mice.

There are benefits to sharing a bed with your pet – as long as you’re scrupulously clean

Retrieved on: 
Lundi, février 5, 2024
Sleep, COVID-19, Parasitism, Sleep hygiene, Life expectancy, MRSA, Science, Research, Human, Allergy, Bacteria, Irritation, MITES, Canis, Environment, Virus, Dog, Head, Plague, Injury, Pet, Saliva, Fluffy, Dust, Loneliness, Risk, Infection, Tick, Fungus, Accident, Cat, Health, Bed, Movement

Perhaps the cat curls up at the end of your bed.

Key Points: 
  • Perhaps the cat curls up at the end of your bed.
  • Maybe the dog dives under the duvet or pops their head on your pillow.
  • But if you do share your bed with Fluffy or Fido, what what does science suggest is best practice?

Disturbed Sleep

  • One challenge of sharing your bed with your pet could be disturbed sleep.
  • The movement of sleeping partners (two or four-legged) may lead to reduced sleep efficiency, although a bed large enough to accommodate all can mitigate this.
  • Encouraging your pet to sleep elsewhere, but within the bedroom could also be beneficial if sleep disturbance is affecting your wellbeing.

Bed bugs

  • These ectoparasites might hop from our pets to us and either cause transient or more prolonged irritation.
  • Indeed, we can even share infections with our pets – including COVID-19 – so it’s not all one-sided.

Allergies and injuries

  • Minor, unintentional injuries such as scratches can occur.
  • Contact with dust and dander from pet hair can be prolonged when in close proximity.

Keeping it clean

  • Advice suggests that at least weekly washing of bed sheets is good practice.
  • If you share your bed with pets, washing bedclothes every three to four days is suggested.
  • The fur and feet of our pets can be contaminated with dirt and pathogens too.

It’s bedtime

  • Balancing the potential downsides of sharing a bed with your pet, with possible benefits is important to assess whether it is a good choice for you or not.
  • With good hygiene and management, the choice to share your sleep with your pet might just give you both a great night’s sleep.


Jacqueline Boyd is affiliated with The Kennel Club (UK) through membership, as Chair of the Activities Health and Welfare Subgroup and member of the Dog Health Group. Jacqueline is a full member of the Association of Pet Dog Trainers (APDT #01583) and she also writes, consults and coaches on canine matters on an independent basis, in addition to her academic affiliation at Nottingham Trent University.

UVDI Debuts Expanded UV Surface Disinfection Portfolio at Arab Health 2024

Retrieved on: 
Lundi, janvier 29, 2024
Data Management, Medical Devices, Health, IOT (Internet of Things), Technology, Hospitals, Hospital, Health care, Multimedia, CRE, Disinfectant, MRSA, Tablet, Atmosphere, Sewage treatment

Today at Arab Health 2024, Ultraviolet Devices, Inc. (UVDI), a global leader in UV air and surface disinfection, introduced the new UVDI-GO™ UV LED Surface Sanitizer and the next generation UVDI-360 Room Sanitizer with UV Smart Connect™ cloud communications.

Key Points: 
  • Today at Arab Health 2024, Ultraviolet Devices, Inc. (UVDI), a global leader in UV air and surface disinfection, introduced the new UVDI-GO™ UV LED Surface Sanitizer and the next generation UVDI-360 Room Sanitizer with UV Smart Connect™ cloud communications.
  • UV Smart Connect™ communications automatically transfers device use and device health data to the UVDI 360° digital hub after every room treatment cycle.
  • UVDI will also showcase the new UVDI-GO™ UV LED Surface Sanitizer, featuring advanced UV LED technology for fast, on-the-go disinfection of high-touch, shared surfaces by trained Healthcare professionals.
  • “Our expanded portfolio of high-performance, no-touch UV disinfection products provides Healthcare professionals with proven tools to combat high-risk microorganisms throughout their facilities,” stated Richard Hayes, President, UVDI.